Informationsdienst Wissenschaft

Improving the treatment of Lassa fever – first clinical trial with favipiravir shows promising results

Favipiravir for Lassa fever: an open-label, randomized controlled phase II trial. Nature Medicine 2026, DOI: 10.1038/s41591-026-04402-w ...